Mauna Kea Technologies signs Half-Year Liquidity Contract Statement with Gilbert Dupont
01/21/25, 4:56 PM
Location
Industry
medical device
biotechnology
health care
manufacturing
Type
contract
Mauna Kea Technologies has signed a half-year liquidity contract statement with the brokerage firm Gilbert Dupont. Under the liquidity contract, resources appeared on the liquidity account on December 31, 2024.
Company Info
Location
paris, ile de france, france
Additional Info
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions.